On December 3, 2008, CMS is hosting a special open door forum teleconference to obtain feedback on the Competitive Acquisition Program (CAP), under which physicians may acquire certain Part B drugs from an approved CAP vendor, rather than buying and billing the drugs directly. On September 10, 2008, CMS announced that the 2009 Medicare Part B drug competitive acquisition program (CAP) is being postponed indefinitely. In the meantime, CMS is considering making changes to the CAP. The agency invites public comments on the program, including: the categories of drugs provided under the CAP; the distribution of areas that are served by the CAP; and procedural changes that may increase the program's flexibility and appeal to potential vendors and physicians. Feedback will be accepted at the teleconference or through email.